Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel E. Tracey(Abbott (United States)), Paul P. Tak(Celldex Therapeutics (United States)), Eric H. Sasso(ScienceSouth), Jochen Salfeld(Abbott (United States)), Lars Klareskog(Karolinska University Hospital)
Cited by 1,614
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
|Arthritis & Rheumatism|2005|1.5k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
|New England Journal of Medicine|2007|1.1k